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Abstract 
Background: Nested PCRs based on the Plasmodium 18s-rRNA gene have been extensively used for human malaria 
diagnosis. However, they are not practical when large quantities of samples need to be processed, further there have 
been challenges in the performance and when interpreting results, especially when submicroscopic infections are 
analysed. Here the use of “direct PCR” was investigated with the aim of improving diagnosis in the malaria elimination 
era.
Methods: The performance of the Plasmodium cytochrome oxidase III gene (COX-III) based novel malaria detection 
strategies (direct nested PCR and direct single PCR) were compared using a 18s-rRNA direct nested PCR as a reference 
tool. Evaluations were based on sensitivity, specificity and the ability to detect mixed infections using control blood 
spot samples and field collected blood samples with final species diagnosis confirmation by sequencing.
Results: The COX-III direct PCR (limit of detection: 0.6–2 parasites/μL) was more sensitive than the 18s-rRNA direct 
nested PCR (limit of detection: 2–10 parasites/μL). The COX-III direct PCR identified all 21 positive controls (no mixed 
infections detected) while the 18s-rRNA direct nested PCR identified 18/21 (including four mixed infections). Different 
concentrations of simulated mixed infections (Plasmodium vivax and Plasmodium falciparum) suggest that the COX-III 
direct PCR detects only the predominant species. When the 18s-rRNA direct nested PCR was used to detect Plasmo-
dium in field collected bloods spots (n = 3833), there was discrepancy in the results from the genus PCR (16 % posi-
tive) and the species-specific PCR (5 % positive). Further, a large portion of a subset of these positive samples (93 % 
for genus and 60 % for P. vivax), did not align with Plasmodium sequences. In contrast, the COX-III direct PCR clearly 
identified (single bands confirmed with sequencing) 2 % positive Plasmodium samples including P. vivax, P. falciparum, 
Plasmodium malariae and Plasmodium ovale wallikeri.
Conclusions: The COX-III single direct PCR is an alternative method for accurate detection of Plasmodium micro-
scopic and submicroscopic infections in humans, especially when a large number of samples require screening. This 
PCR does not require DNA isolation, is sensitive, quick, produces confident/clear results, identifies all the Plasmodium 
species infecting humans, and is cost-effective.
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Background
Significant progress has been made in the global fight 
against malaria through the scaling-up of indoor residual 
spraying (IRS), insecticide-treated bed nets (ITNs), rapid 
diagnostic tests (RDTs) and artemisinin-based combina-
tion therapy (ACT) [1, 2]. As malaria endemic regions 
approach pre-elimination, a switch from passive detec-
tion to active screening of large numbers of samples will 
be needed to find and treat asymptomatic infections [3]. 
Design and implementation of sensitive diagnostic tools 
are thus needed to detect asymptomatic infections that 
would otherwise go unnoticed and contribute to the per-
sistence of malaria transmission [4].
Estimates of human malaria prevalence and inci-
dence are dependent on the sensitivity of the diagnostic 
method. Under field conditions, experienced microsco-
pists typically detect parasitaemias of 50–100 parasites/
µL [5], but misdiagnosis is common with mixed infec-
tions and low parasitaemias are often missed. In areas 
where microscopy is not feasible, rapid malaria diag-
nostic tests (RDTs) target the lactate dehydrogenase 
and aldolase proteins found in all Plasmodium species 
(Pan-specific malaria RDT). The histidine-rich protein 
2 (HRP2) based RDT is specific for Plasmodium falci-
parum [6]. These RDTs have a limit of detection around 
200 parasites/µL and are influenced by other factors such 
as deletion of target genes, the method of storage and 
handling of RDTs, concentration of proteins in blood, the 
manufacturer and subjectivity in interpretation of results 
which may affect the accuracy of the tests [7–11].
Molecular tools have also been utilized for malaria 
diagnosis and have improved the capacity to diagnose 
submicroscopic infections [12, 13]. These are defined as 
a low-density of Plasmodium parasites in blood that are 
unlikely to be detected by conventional microscopy. A 
meta-analyses of 38 studies comparing the sensitivity of 
microscopy and PCR for malaria diagnosis demonstrated 
that an average of 69 and 56 % of Plasmodium vivax and 
P. falciparum infections, respectively, identified as posi-
tives through PCR were not detected by microscopy [12].
Since the early 1990s, PCR-based diagnostic meth-
ods targeting the small subunit rRNA gene (18s-rRNA) 
have been routinely used for the detection of human 
Plasmodium species [14–16]. A nested PCR using this 
gene is considered the standard for molecular-based 
malaria diagnosis [3]. The reported diagnostic sensitiv-
ity of tests based on the 18s-rRNA target ranges from 1 
to 10 parasites/µL [16–18]. This nested PCR, as well as 
the mitochondrial cytochrome b [19, 20], antigenic genes 
such as stevor and msa-2 [21], PgMt19 and PfMT869 
mitochondrial regions [22], and the Pvr47 and Pfr364 
genes [23, 24], have allowed screening of field samples 
for epidemiological studies and characterization of sub-
microscopic malaria infection. However, the level of sen-
sitivity is variable depending on the method used and 
characteristics of the target gene.
Recently, a novel technique called “direct PCR”, was 
developed based on DNA amplifications using a geneti-
cally modified DNA polymerase with rapid performance 
in presence of strong inhibitors from blood [25]. As a 
consequence, DNA extraction and PCR amplification 
can be combined in a single step, saving resources and 
time, while minimizing human error and contamina-
tions. Direct PCRs has been used to diagnose infectious 
diseases [17, 26], to detect molecular markers of cancer 
[27], to identify human pharmacogenomics markers for 
HIV [28], for forensic genotyping [29] and was applied to 
malaria diagnosis using the 18s-rRNA following a nested 
PCR approach [17, 30].
Nested PCRs are still routinely used to identify Plas-
modium genus and species. This may be impractical for 
diagnosis in the malaria elimination era, where the pro-
portion of submicroscopic infections are expected to 
increase [4, 31] and larger number of samples will be 
required for human malaria epidemiology studies. The 
main goal of this study is to provide faster and more sen-
sitive molecular tools to improve malaria diagnosis in 
the era of malaria elimination programmes. The use of a 
direct single PCR based on the Plasmodium cytochrome 
oxidase gene (COX-III) was investigated and compared 
against the 18s-rRNA direct nested PCR for malaria 
diagnosis.
Methods
Parasite reference strains and positive control blood 
samples
Malaria parasites (in blood spots or as extracted DNA) 
from P. falciparum (HB3 strain), P. vivax (AMRU1 and 
MIAMI strains), Plasmodium ovale (I.D 5463) and Plas-
modium knowlesi (Malayan strain) were provided by 
Michael Ferdig (University of Notre Dame, USA), Rob-
ert D. Cooper (Australian Army Malaria Institute, Aus-
tralia) and the Malaria Research and Reference Reagent 
Resource Center (MR4) USA, Harald Noedl (Medical 
University of Vienna, Austria), and John W. Barnwell 
(Centers for Disease Control and Prevention, USA), 
respectively. Microscopy was used to determine para-
site densities of P. vivax (AMRU1) obtained from Aotus 
monkeys and P. falciparum (HB3) from continuous cul-
ture (about 70 % rings), which were serially diluted and 
blotted on filter paper ranging from 500 to one parasites/
μL and 500–0.06 parasites/μL, respectively. Twenty-one 
malaria positive (as diagnosed by microscopy) blood 
samples were included as positive controls.
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Field human blood samples collection
A total of 3833 finger-prick human blood samples 
were collected in the Western Province of the Solomon 
Islands. Blood was spotted onto filter paper (Whatman 3 
MM, Whatman International, Maidstone, England) and 
air dried at ambient temperature before storage in indi-
vidual plastic bags with silica gel. Ethical approval for 
the study was obtained from University of Notre Dame, 
USA (FWA 00002462); National Health Research and 
Ethics Committee, Solomon Islands (HRC13/14 and 
HRC14/16); and the James Cook University Human 
Research Ethics Committee, Australia (H4915). Informed 
consent was sought from all the subjects who provided 
blood samples.
Preparation of blood spots
For each sample, two 1.5 mm diameter samples of dried 
blood (equivalent to 3–5 µL of blood) [32] were placed in 
the well of a 96-well PCR microplate (Axygen Scientific, 
Union City, CA). Each plate included two positive con-
trols (P. vivax or P. falciparum) and three negative con-
trols (two blood spots from a known malaria negative 
donor and one no-template reaction control). To remove 
haemoglobin, 70  µL of molecular biology grade water 
(Cellgro–Mediatech INC, Manassas, VA) were added to 
each well and the plate was incubated at 50 °C for five min, 
21 °C for 15 s, 50 °C for 1.5 min, and 21 °C for 15 s. The 
water was then removed from each well and discarded.
Malaria genus PCR based on the 18s‑rRNA (direct nested 
PCR)
A direct nested PCR strategy targeting the 18s-rRNA 
gene using the Blood Phusion Direct PCR Kit (Thermo 
Scientific, Waltham, MA) as described by Fuehrer et  al. 
[17] was followed with modifications (Table  1). For the 
nest1 protocol, a total master-mix volume of 25 µL was 
added directly to the wells containing blood spots (Fig. 1, 
Table 1). After nest1 completion, the microplate was cen-
trifuged at room temperature at 1000 G for 3 min. 3 µL of 
nest1 PCR product were transferred to a new microplate 
in order to perform the nest2 reaction (Fig.  1, Table  1) 
with a final volume of 20 µL. Nest2 PCR products were 
analysed by gel electrophoresis in a 1.5  % agarose gel 
stained with ethidium bromide (Sigma-Aldrich, St. Louis, 
MO).
18s‑rRNA PCR for Plasmodium vivax 
and Plasmodium falciparum diagnosis
Malaria-species diagnosis [17] (nest2 PCR) was per-
formed on positive samples from the malaria-genus PCR 
(presence of a 235  bp band), on the reference strains 
serial dilutions and on 21 positive control samples. As 
P. vivax (band of 121  bp) and P. falciparum (band of 
200 bp) are the most prevalent species worldwide, sepa-
rate rounds of nest2 PCRs were performed for diagno-
sis of both species using 3 µL of nest1 PCR product and 
a master-mix volume of 15  µL (Fig.  1, Table  1). Nest2 
PCR products were analysed as above using a 2.0 % aga-
rose gel. All 18s-rRNA PCR assays were amplified on an 
Eppendorf Master Cycler (Eppendorf ) or GeneAmp PCR 
System 9700 (Applied Biosystems) machines.
Cytochrome oxidase III primer design
The mitochondrial genome sequences (~5900 nucleo-
tides) from P. vivax [GenBank: KF668441.1], P. falci-
parum [GenBank M99416.1], Plasmodium malariae 
[GenBank AB489194.1], Plasmodium ovale wallik-
eri [GenBank HQ712053.1], Plasmodium ovale cur-
tisi [GenBank HQ712052.1], and P. knowlesi [GenBank 
AY722797.1] were aligned using MultAlin software [33]. 
A visual inspection of the alignment demonstrated sev-
eral blocks of polymorphic sequences delimitated by con-
served sequences among the Plasmodium species around 
the cytochrome oxidase III (COX-III) gene (Fig. 1). A set 
of primers, plas_cox3F/R (for nest1) and short_COX-III 
F/R (for nest2) (Table 1), were designed with the highest 
stringency in parameters using the DNAstar lasergene® 
11 software (DNAstar Inc. Madison WI). The annealing 
temperatures for these primers were determined using 
the manufacturer’s instructions [34].
COX‑III Nested and single direct PCR
Haemoglobin was removed as described. For the nest1 
COX-III direct PCR the final reaction volume was 25 μL 
(Table  1). A nest2 PCR was then performed using 2  uL 
of the nest1 PCR product in a final reaction volume of 
25  μL. For the single direct PCR reactions, the primers 
short COX-III F/R were used in a 25  μL final volume 
(Fig. 1, Table 1). PCR products were visualized on a 1 % 
gel stained with SYBR®safe (Invitrogen, Carlsbad, CA).
Mixed infection test using the fast COX‑III PCR
To estimate the performance of the single direct COX-
III PCR on simulated mixed infections, the genomic 
DNA from P. falciparum (HB3 strain) and P. vivax 
(Miami strain) cultures were extracted following the 
protocol described in the E.Z.N.A. Blood DNA Mini Kit 
(Omega Bio-Tek, Norcross, GA). The concentration of 
the extracted DNA was determined using the Nanodrop 
2000 (Thermo Scientific, Waltham, MA). Eight serial 
dilutions with a 1:6 factor were prepared for each species 
DNA. Serial dilutions from one species (from the highest 
to the lowest) were mixed with the serial dilutions from 
the other species (from the lowest to the highest) resem-
bling different concentrations of DNAs found in Plasmo-
dium spp. mixed infections (Table 2).
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Fig. 1 Flowchart of PCR techniques and alignment of the Plasmodium cytochrome oxidase gene III PCR products. For the cytochrome oxidase III 
(COX-III) gene the expected sizes of PCR fragments are: P. vivax (506 bp), P. falciparum (508 bp), P. malariae (504 bp), P. knowlesi (499 bp), P. ovale wal-
likeri and P. ovale curtisi (506 bp). With the COX-III gene sequence alignment, 140 polymorphisms (28 % of nucleotides) provide information for spe-
cies diagnosis (there are eight blocks of highly polymorphic regions). For differentiation between P. ovale wallikeri and P. ovale curtisi, 16 SNPs were 
found (green arrows). When using 18s-rRNA nested PCR, additional Nest2 PCRs with species-specific primers are required for diagnosis of P. malariae, 
P. ovale wallikeri, P. ovale curtisi and P. knowlesi
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Sequencing reactions for species diagnosis
A set of 100 predictive positive samples for the 18s-rRNA 
genus malaria diagnosis (with PCR product around 
235 bp PCR product), and 20 from the species malaria P. 
vivax PCR (approx. 121 bp) were excised from gels and 
purified using the QIAquick gel extraction kit (QIAGEN, 
Valencia, CA) and sequenced with the rPLU3, Plasmo_
int_2REV (3′ CATCAAAAGCTGATAGGTCAGA 
5′–200  bp sequence length) and VIV1 primers respec-
tively (Table  1). Eight microliter of PCR product from 
positive samples from COX-III single direct PCR reac-
tions were purified with the ExoSAP-IT PCR clean-up 
kit (Affymetrix, Santa Clara, CA) and sequenced with 
the short_COX-IIIF primer. All sequencing reactions 
were performed on a MicroAmp Optical 96-well plate 
(Life Technologies) following the protocol described in 
the BigDye® Terminator V3.1 kit (Applied Biosystems). 
The BigDye® was precipitated and samples were re-
suspended in 10 µL of Hi-Di Formamide and sequenced 
on an ABI 3730XL 96-capillary sequencer. Analyses of 
sequences were performed using the DNASTAR Laser-
gene ® 11 software (DNAstar Inc. Madison WI).
Results
Lowest parasitaemia detected and validation assay 
on positive blood samples
The lowest parasitaemia detected by PCR diagnostic 
assays were estimated using serial dilutions from para-
site reference strains ranging from 500 to 0.06 para-
sites/μL. The lowest parasitaemia consistently detected 
for P. falciparum and P. vivax with the 18s-rRNA direct 
nested PCR (in 4/4 replicates) were 2 and 10 parasites/
μL, respectively, while for the single direct COX-III PCR 
was 0.6 parasite/μL for P. falciparum and 2 parasites/μL 
for P. vivax (in 6/6 replicates) (Fig.  2a, b). Interestingly, 
the COX-III single direct PCR performed similar to or 
better than the nested COX-III PCR (data not shown). 
Since the COX-III single direct PCR was found to be 
simpler, shorter and more sensitive, the nested COX-
III PCR was not analysed further. The addition of extra 
blood spots from negative malaria donors into a reaction 
did not affect the performance of the single direct COX-
III PCR at the lowest P. falciparum detected parasitaemia 
(Fig. 2b).
When the 18s-rRNA nested PCR was validated with 
the 21 known positive blood samples, the test showed 
that all samples were positive with the genus malaria 
PCR (Fig. 2c) and with the species diagnosis as follows: P. 
falciparum (n = 7), P. vivax (n = 5), P. malariae (n = 1), 
P. ovale (n = 1) and mixed infection (n = 4) (Fig. 2d), and 
three samples did not amplify with any of the species-
specific primers (Table 3). The COX-III single direct PCR 
amplified the expected band of 500  bp, and sequenced 
all the human Plasmodium parasites used as controls, 
including all the 21 known positive blood samples (100 % 
concordance with the 18s-rRNA genus malaria PCR) 
(Tables 2, 3). When compared with the 18s-rRNA nested 
PCR, the COX-III sequencing results confirmed species 
identification results for 14 samples and identified the 
missed three as P. malariae; the predicted four mixed 
infections were identified as mono-infections by either P. 
vivax or P. falciparum (Table 3).
Mixed infection test using the fast COX‑III PCR
The performance of the COX-III single direct PCR on 
simulated mixed infections was tested using a range 
from 0.33 to 1.2E-06 ng of DNA from P. falciparum (HB3 
strain) and P. vivax (Miami strain) (Table 2). For all the 
different ratios of DNA concentrations in the simulated 
mixed-infection, the band of about 500 bp was obtained 
in four independent assays. Sequencing of the COX-III 
PCR products identified the malaria parasite (P. vivax or 
Table 2 Analyses of  PCR products (COX‑III single direct‑
PCR) of  Plasmodium spp positive‑controls and  dilution 
performance of simulated mixed infections
Serial dilutions 1:6 of eight different mixed concentration of DNA (higher for one 
species and lower for the other, and vice versa)
Plasmodium spp. BLAST result
% Identity E value
Plasmodium spp. control (positive) samples
 P. falciparum (HB3 strain) 99.8 0.0
 P. vivax (AMRU1 strain) 100 0.0
 P. malariae (From the field) 99.8 0.0
 P. ovale wallikeri (I.D 5463) 99.3 0.0
 P. ovale curtisi (From the field) 98.4 3.2E−113
 P. knowlesi (Malayan Strain) 100 8.1E−180
Serial dilutions of mixed samples in ng (higher concentration of P. vivax 
Miami strain)
 3.3 E−01 P. vivax + 1.1E−06  
of P. falciparum
98.5 P. vivax 2.9E−93
 5.5 E−02 P. vivax + 7.14E−06  
of P. falciparum
 9.2 E−03 P. vivax + 4.2E−05  
of P. falciparum
 1.5 E−04 P. vivax + 2.5 E−04  
of P. falciparum
Serial dilutions of mixed samples in ng (higher concentration of P. falcipa-
rum HB3 strain)
 2.5 E−04 P. vivax +1.5 E−04  
of P. falciparum
99.5 P. falciparum 9.4E−100
 4.2E−05 P. vivax + 9.2 E−03  
of P. falciparum
 7.14E−06 P. vivax + 5.5 E−02  
of P. falciparum
 1.1E−06 P. vivax + 3.3 E−01  
of P. falciparum
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P. falciparum) that had the higher concentration of DNA 
for a given simulated mixed-infection (Table 2).
Validation of protocols on field samples
18s‑rRNA direct nested PCR
A total of 3833 samples were screened for malaria using 
the modified 18s-rRNA direct nested PCR (Table  1, 
Fig.  1). There were 636 (16.6  %) Plasmodium positive 
samples with the 235  bp diagnostic band. Faint bands 
around 235  bp were found singularly or accompanied 
with strong bands usually above 300 bp without evidence 
of contamination in the negative control wells. These 
non-specific amplifications were seen in almost 85 % of 
all Plasmodium genus PCRs performed (Fig. 3a).
There was a lack of concordance between the genus 
and species PCRs using the 18s-rRNA direct nested diag-
nostic assay. All Plasmodium PCR positive samples were 
only tested for P. falciparum and P. vivax (Fig. 1). About 
30  % of the positive genus-Plasmodium samples were 
positive by species-specific PCR. A total of 179 infections 
(95.2 %) were diagnosed as P. vivax and nine (4.8 %) by 
P. falciparum (overall, 4.9  % of samples were positive). 
Again, non-specific bands were seen above 300  bp and 
close to the diagnostic band for P. vivax (Fig. 3b) and P. 
falciparum. The 448/636 samples that did not amplify 
any of the malaria species, were rerun with the P. vivax 
specific primers (as this is the most prevalent species in 
the tested samples). For this set of samples amplifications 
were not obtained.
A total of 100 and 20 predicted positive samples were 
sequenced to verify Plasmodium spp. and P. vivax diag-
nosis respectively (Fig. 3b). For the sequencing reactions 
with Plasmo_int_2REV or rPLU4 primers, only seven 
samples were identified as P. vivax. For the remaining 93 
samples, the sequencing results were inconclusive or did 
not have similarity with any sequence from GenBank. For 
the 20 sequencing reactions run with VIV1 primer, eight 
samples showed similarity with P. vivax, four were human 
DNA, and eight had no similarity with any sequence.
COX‑III single direct PCR
The COX-III single direct PCR approach was used for 
Plasmodium spp. detection in the 3833 samples. The 
diagnostic band of 500 bp was seen in 79/3833 samples 
(2  % of positive samples) (Fig.  3c). In these samples, a 
total of 39 and 40 samples were positive from the pre-
viously 640 predicted positive and negative samples 
using the 18s-rRNA direct nested PCR, respectively. 
When comparing the 3833 set of samples with both PCR 
approaches (18s-rRNA and COX-III), the COX-III direct 
PCR detected only 6 % of the 640 predicted positives by 
the nested PCR.
Fig. 2 Lowest parasitaemia detected for the COX-III single direct-PCR and the 18s-rRNA nested-PCR on positive controls. a The lowest for P. vivax 
was 2 parasites/μL using the COX-III based PCR (expected fragment around 500 bp). b For P. falciparum (with COX-III PCR) was 0.6 parasites/μL. 
Adding one blood spot from healthy donors A and B to the parasite dilutions did not affect the PCR performance. Donor’s blood did not amplify 
any bands. c Performance of the 18s-rRNA genus-malaria nested PCR on nine positive control samples collected in the field (band of 235 bp). 
Non-specific bands are present. d Plasmodium vivax (121 bp), P. falciparum (200 bp) and a mixed infection detected in positive controls using the 
species-specific nested PCR
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Overall, from the 79 sequenced samples with the 
short_COX-IIIF primer, 76  % were P. vivax, 12  % were 
P. falciparum, 8  % were P. ovale wallikeri and 4  % were 
P. malariae. A further 3506 blood spots were also tested 
with this protocol with similar results (data not shown). 
This method also generated clearer diagnostic bands 
without non-specific bands (Fig. 3c).
Discussion
Since 1993, the 18s-rRNA gene has been extensively used 
in different PCR assays for malaria diagnosis [14, 15, 30, 
35–38]. The nested PCR approach has been the most 
widely used and often regarded as the standard PCR 
diagnostic method (primarily using high purity DNA and 
the original protocol), when comparing new PCR-based 
diagnostic approaches [17, 19, 23, 39, 40]. The 18s-rRNA 
nested PCR was not designed to be used with crude 
blood spots in a direct PCR strategy.
In the present study, the limit of detection or sensitiv-
ity, using the 18s-rRNA direct nested PCR was 2 and 10 
parasites/μL for P. falciparum and P. vivax respectively, 
which is comparable with previous studies [16–18]. Only 
18 of 21 positive control blood spot samples were posi-
tives for genus and species, with the three P. malariae 
samples being not detected by the18s-rRNA nested PCR. 
Whereas, all 21 positive control samples were detected 
by the COX-III single direct PCR.
Several studies have described inconsistencies in 
malaria positivity rates when species-specific reactions 
are performed using the 18s-rRNA gene [14, 19, 41–43] 
(Table  4). Several problems were identified when using 
the nested PCR to analyse the field samples: (a) 75 % of 
positive samples gave discordant diagnoses when genus 
and species-specific results were compared; (b) it was not 
possible to confirm predictive positive samples (genus 
and species PCR) with sequencing; and (c) 40 samples 
positive with the COX-III single direct PCR were not 
identified with the18s-rRNA genus nested PCR. Possi-
ble explanations for the results from the nested protocol 
include the following:
1. Amplification of non-specific bands: The amplifica-
tion of non-specific bands in the nested PCR diag-
nostic have been described [23, 44] and reported 
with the primers PLF, UNR and VIR (also targeting 
the 18s-rRNA gene) [45]. Sequencing of a subset of 
predicted positive samples for genus and species 
did not produce readable data (93 % and 55 % of the 
samples tested respectively), suggesting non-specific 
amplification. Without evidence of contamination in 
the negative controls, the presence of non-specific 
bands near or at the expected diagnostic band size 
increased the number of false positives.
2. Lower DNA yield from blood spots: The number of 
parasites can differ by more than 15 % between dif-
ferent punches from the same bloodspot [22]. It is 
also suggested that samples analysed from dried 
blood spots report half the Plasmodium positive rate 
compared with analyses using whole blood samples 
[23]. Samples in this study are from a low transmis-
sion setting (Western Province, Solomon Islands) 
under malaria pre-elimination phase, and may have 
extremely low parasite densities, which may fail to 
amplify (Monte Carlo effect) [43] or produce incon-
sistent or unspecific amplifications with a protocol 
not sensitive enough.
3. The methodology described by Fuehrer et al. [17] uti-
lized phusion blood DNA polymerase, while in this 
study the phusion blood II DNA polymerase was 
Table 3 Comparison of  malaria diagnosis on  21 positive 
samples based on the COX‑III single direct‑PCR versus the 
18s‑rRNA nested PCRs
a  Negative results was obtain in two independent experiments
b  Mixed infections were due to P. falciparum and P. vivax
c  A second technical replicate of this sample was showed as a mono-infection 
with P. vivax
Sample code PCR fragment 
of COX‑III
PCR fragment 
of 18s‑rRNA
Agreement
Genus Species
IN01 P. malariae + Negativea No
IN02 P. falciparum + P. falciparum Yes
IN03 P. falciparum + P. falciparum Yes
IN04 P. falciparum + P. falciparum Yes
IN05 P. vivax + P. vivax Yes
IN06 P. vivax + P. vivax Yes
IN07 P. vivax + Mixed  
infectionb
No
IN08 P. falciparum + P. falciparum Yes
IN09 P. vivax + P. vivax Yes
IN10 P. falciparum + P. falciparum Yes
IN11 P. vivax + Mixed  
infectionb, c
No
IN12 P. vivax + Mixed  
infectionb
No
IN13 P. malariae + P. malariae Yes
IN14 P. falciparum + Mixed  
infectionb
No
IN15 P. ovale curtisi + P. ovale Yes
IN16 P. malariae + Negativea No
IN17 P. vivax + P. vivax Yes
IN18 P. vivax + P. vivax Yes
IN19 P. malariae + Negativea No
IN20 P. falciparum + P. falciparum Yes
IN21 P. falciparum + P. falciparum Yes
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Fig. 3 Performance of the 18s-rRNA nested-PCR and COX-III single direct-PCR on samples from the Solomon Islands. a Strong non-specific bands 
in 14 samples were amplified when the genus-malaria 18s-rRNA nested PCR was used. The expected diagnostic band for Plasmodium spp is 235 bp 
(red arrow). b Nonspecific bands close to the 121 bp diagnostic bands for P. vivax (blue arrow); only the sample 13 shown a robust band. c Eighteen 
samples tested for Plasmodium spp using the COX-III gene, a band of approximately 500 bp (green arrow) represent positive samples
Table 4 Summary of inconclusive results when the 18s‑rRNA species‑specific primers are used for malaria diagnosis
a  18s-rRNA genus were positive but no species identified by nested PCR
b  The genus diagnostic was based on mitochondrial DNA while specie-specific diagnosis targeted the 18s rRNA
c  13 samples were tested by quadruplicate with species-specific primers without reproducible results
d  Results from P. falciparum specific primers (rFAL1/rFAL2) were compared against composite reference results
Location Proportion of inconsistent  
species‑specific  
identification over total  
predicted positives for genus (%)
Source material (DNA extraction method) References
Cambodia 12/256 (4.7)a Blood spots (commercial kit and instagene) [19]
Tanzania 21/76 (27.6)b Whole blood (commercial kit) [41]
Brazil 13/34 (38)c Whole blood (commercial kit) [43]
Malaysia 3/46 (6.5)a Blood spots (chelex) [14]
Bangladesh 2/97 (2)a Blood spots (direct PCR) and (instagene-chelex) [17]
Nigeria 37/285 (13)d Blood spots (commercial kit) [21]
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used. The phusion blood II DNA polymerase in the 
direct PCR kit contains an improved affibody mol-
ecule which allows for lower annealing temperatures 
and wider range of PCR primers, this may explain the 
non-specific bands seen here, and may require extra 
optimization of temperatures with a gradient cycler. 
This issue was not seen when the phusion blood 
DNA polymerase was used.
4. Presence of blood inhibitors: Blood has potent PCR 
inhibitors such as haemoglobin, hemin, immuno-
globulin G and lactoferrin [46, 47]. In PCR reactions, 
the Taq polymerase enzyme is completely inhibited 
in the presence of 0.004 % (v/v) of human blood [48]. 
Blood compounds transferred from the first PCR 
product (nest1) to the second (nest2) PCR reaction 
might affect amplification of target DNA.
The lowest parasitaemia detected with the COX-III 
single direct PCR (≤2 parasites/ul found in P. vivax and 
P. falciparum) is comparable with malaria diagnostic 
techniques based on mitochondrial or Pfr364 and Pvr47 
genes, LAMP isothermal reactions, real time PCR and 
single PCRs [23, 39, 49, 50]; and better when compared 
with 18s-rRNA isothermal reactions, real time and mul-
tiplex PCRs [37, 51, 52]. Differences in sensitivity are 
correlated with: (1) higher copy numbers of COX-III 
and other mitochondrial genes (up to 150) in compari-
son with up to 8 copies in the 18s-rRNA gene [40], (2) 
stringent design of primers (100 and 66  % similarity 
with Plasmodium and human DNA respectively) and 
(3) the robustness and accuracy of the phusion blood 
II DNA polymerase used in the direct PCR. In a recent 
manuscript, a new efficient PCR (one round) based 
on the COX-III gene (using purified DNA) for Plasmo-
dium genus detection was described, with nested PCRs 
required for Plasmodium species identification [40].
The use of direct PCR avoids DNA extraction/purifica-
tion steps, thereby retaining all DNA in the sample while 
reducing the risk of cross-contamination. The practicality 
and shorter time-to-result with the single COX-III direct 
PCR (1  h) compared with other PCR assays make this 
technique suitable for large-scale application and high-
throughput analyses, while also dramatically reducing 
time, effort and resources. The single COX-III direct PCR 
is also less expensive. The cost of malaria diagnosis of 96 
blood spots with 10 positive samples (for species identi-
fication) using the single direct COX-III PCR (including 
only the single COX-III PCRs, PCR product purifica-
tion and sequencing) can be up to a quarter of the cost 
when compared with the 18s-rRNA nested PCR (192 
PCRs for genus diagnosis and 50 for species diagnosis) 
as described here, the COX-III PCR assay developed by 
Isozumi et al. [40], and a 18s-rRNA real time PCR strat-
egy [39].
Only a few protocols have been designed to discrimi-
nate between the species P. ovale curtisi (classic type) and 
P. ovale wallikeri (variant type) [18, 53]. There are 97 pre-
dicted polymorphisms (88 SNPs and 9 INDELs) between 
the P. ovale wallikeri (HQ712053.1) and P. ovale curtisi 
(HQ712052.1) mitochondrial genomes (5850  bp). The 
COX-III single direct PCR amplifies a 506 bp fragment, 
which has 16 SNPs (16.5 % of the total polymorphisms) 
accounting for an accurate diagnosis for both species. A 
positive control sample from the field was identified as P. 
ovale curtisi while P. ovale wallikeri was found in a ref-
erence control and three samples from the larger dataset 
(Tables 2, 3).
Mixed Plasmodium infection diagnosis is rare (up to 
4  %) with microscopy but common (up to 65  %) when 
PCR techniques are used [54]. The single COX-III 
direct PCR was able to detect only one species in the 
three predicted mixed infections detected by the nested 
18s-rRNA in positive control samples (Table  3). Also, 
the new technique consistently amplified parasite DNA 
in mock mixed infections (P. vivax and P. falciparum), 
but the sequencing reactions only detected the predomi-
nant infection (Table  2). This is consistent with previ-
ous studies when the difference of DNA concentration 
is  >10-fold between parasites in a mixed infection, only 
the most abundant parasite is amplified when multiplex 
PCR or real time techniques are used [51]. The use of 
specific primers for each Plasmodium species may be the 
most precise approach for determining species in mixed 
malaria infections.
Conclusions
In conclusion, a cheaper, faster, and more sensitive PCR/
sequencing method to accurately identify all human 
malaria parasites (including the P. ovale sub-species) was 
developed and tested on more than 7000 blood spots, 
using the cytochrome oxidase III (COX-III) as target. 
This method will simplify screening samples as well as 
minimize chances of contamination as DNA extraction 
and nested PCR reactions are not required. This sensitive 
diagnostic tool will be useful in detecting submicroscopic 
and/or asymptomatic malaria when active screening a 
large number of subjects.
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